<DOC>
	<DOCNO>NCT01346657</DOCNO>
	<brief_summary>The objective study evaluate effect LipoCol Forte® Capsules pharmacokinetics nifedipine administer single-dose combination healthy subject use 2x2 crossover design .</brief_summary>
	<brief_title>The Effect LipoCol Forte® Capsules Pharmacokinetics Nifedipine After Administering Single-dose Combination Healthy Subjects</brief_title>
	<detailed_description>Healthy subject randomly allocate receive single dose either one 5 milgram ( mg ) nifedipine capsule one 5 milgram ( mg ) nifedipine capsule plus one 600 milgram ( mg ) red yeast rice capsule ; 7-day washout period , receive single dose alternative drug . The subject fast least 10 hour dosing . The investigational product administer 240 milliliter ( mL ) water subject upright position . The blood sample collect prior drug administration ( T0 ) , 0.167 , 0.333 , 0.500 , 0.750 , 1 , 1.25 , 1.5 , 2 , 2.5 , 3 , 4 , 6 , 8 , 12 , 14 , 16 24 hour dose .</detailed_description>
	<mesh_term>Nifedipine</mesh_term>
	<criteria>1 . Subjects must age 2040 year old good health basis medical history , physical examination , electrocardiogram , chest Xray , routine laboratory evaluation . 2 . Vital sign ( 3 minute rest upright position ) within follow range : Ear body temperature 35.037.5 degree celsius ( °C ) . Systolic blood pressure , 90140 millimeter mercury ( mm Hg ) . Diastolic blood pressure , 5090 millimeter mercury ( mm Hg ) . Pulse rate , 5090 beat per minute ( bpm ) . Fasting blood glucose , &lt; 110 milligram per deciliter ( mg/dL ) . 3 . Body weight must 50 kilogram ( kg ) within 20 +20 % ideal body weight . 4 . Able sign inform consent prior study . 5 . Able communicate well investigator comply requirement study . 1 . Use prescription medication within 14 day prior dose . 2 . Use overthecounter medication vitamin within 14 day prior dose . 3 . Significant illness within 2 week prior dose . 4 . Participation clinical investigation within 2 month prior dose longer required local regulation . 5 . Donate loss 500 milliliter ( mL ) blood within 3 month prior dose . 6 . Presence cardiovascular disease . 7 . Presence gastrointestinal disease . 8 . Presence asthma lung disease . 9 . Presence liver disease , hepatitis B , hepatitis C liver injury indicate abnormal liver function profile . 10 . Presence impair renal function . 11 . Presence neurological disease . 12 . Presence psychiatrical disease . 13 . Subject know HIV infect . 14 . A known hypersensitivity nifedipine , lovastatin Chinese Red Yeast Rice analog . 15 . History drug alcohol abuse within 12 month prior dose . 16 . Permanent confinement institution . 17 . Individuals judge investigator pharmacokineticist undesirable subject reason .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Nifidipine</keyword>
	<keyword>red yeast rice</keyword>
	<keyword>drug-drug interaction</keyword>
</DOC>